Berlin, Germany – New research is refining our understanding of how best to treat schizophrenia, moving beyond traditional approaches that focus solely on dopamine regulation. A recent network meta-analysis of randomized controlled trials, indexed in both English and Chinese databases, suggests that while differences in efficacy between antipsychotics are often modest, variations in tolerability are … Read more
Source link